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Abstract
Our group has shown that the polysaccharides extracted from Lycium barbarum (LBP) are neuroprotective for retinal
ganglion cells (RGCs) in different animal models. Protecting RGCs from secondary degeneration is a promising direction for
therapy in glaucoma management. The complete optic nerve transection (CONT) model can be used to study primary
degeneration of RGCs, while the partial optic nerve transection (PONT) model can be used to study secondary degeneration
of RGCs because primary degeneration of RGCs and secondary degeneration can be separated in location in the same retina
in this model; in other situations, these types of degeneration can be difficult to distinguish. In order to examine which kind
of degeneration LBP could delay, both CONT and PONT models were used in this study. Rats were fed with LBP or vehicle
daily from 7 days before surgery until sacrifice at different time-points and the surviving numbers of RGCs were evaluated.
The expression of several proteins related to inflammation, oxidative stress, and the c-jun N-terminal kinase (JNK) pathways
were detected with Western-blot analysis. LBP did not delay primary degeneration of RGCs after either CONT or PONT, but it
did delay secondary degeneration of RGCs after PONT. We found that LBP appeared to exert these protective effects by
inhibiting oxidative stress and the JNK/c-jun pathway and by transiently increasing production of insulin-like growth factor-
1 (IGF-1). This study suggests that LBP can delay secondary degeneration of RGCs and this effect may be linked to inhibition
of oxidative stress and the JNK/c-jun pathway in the retina.
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Introduction
Glaucoma has been considered to be a neurodegenerative
disease characterized by optic nerve (ON) atrophy and irreversible
loss of retinal ganglion cells (RGCs) [1]. The loss of RGC bodies
may be primary (caused by direct damage to axons or cell bodies,
such as crush or transection of axons) or secondary (caused by the
toxious effectors released from the neighboring dying cells because
of primary damage or a cell death signal from the deafferented
target) [2–5]. The delay of secondary degeneration of RGCs in
glaucoma is believed to provide a promising avenue for treatment.
Several animal models have been used in the study of glaucoma,
including complete optic nerve transection (CONT), acute and
chronic ocular hypertension models and the ON crush model.
However, it is difficult to distinguish primary degeneration from
secondary degeneration in these commonly used models because
each involves insult to all RGCs [3]. For example, in the CONT
model, all the axons of RGCs are cut and therefore all RGCs will
die from primary degeneration. However, in the partial optic
nerve transection (PONT) model, which was established about ten
years ago, only axons in the dorsal part of ON are transected. The
degeneration of the cell bodies of RGCs whose axons are
transected during surgery is primary and the degeneration of the
cell bodies of RGCs whose axons are intact during surgery is
secondary. According to the literature, primary degeneration
mainly happened in superior retinas and secondary in inferior
retinas, they could be separated in location. [2]. Oxidative stress
has been thought to be involved in secondary degeneration after
PONT, even though stringent measures are taken to ensure
adequate retinal circulation [6–8]. Inflammation has also been
shown to be involved in secondary degeneration after brain
trauma and spinal cord injury. However, its involvement in
secondary degeneration of RGCs after PONT has not been
studied.
Lycium barbarum has been used as an ‘‘upper class herb’’ for
hundreds of years in the Oriental world. It was used for the
treatment of the diseases related to vision, the ‘‘kidney’’ and the
‘‘liver’’ [9]. We have shown that the polysaccharides extracted
from Lycium barbarum (LBP) reduce the death of cultured cortical
neurons challenged by beta-amyloid, glutamate and Homocyste-
ine [10–13]. LBP also delay the degeneration of RGCs in a rat
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chronic ocular hypertension model [14] and a mouse acute ocular
hypertension model [15] and reduce neuronal damage in a mouse
transient middle cerebral artery occlusion model [16]. However, it
is difficult to know whether LBP delayed primary or secondary
degeneration in these models, and the mechanism or mechanisms
underlying the neuroprotective effects of LBP for neuronal tissues
remained unclear.
The aims of this experiment were to confirm whether ON
section caused retinal oxidative stress, to investigate the presence
of retinal inflammation after ON section and to determine which
kind of degeneration LBP could delay and which mechanism(s)
might be involved in any neuroprotective effects of LBP, and we
were largely successful in these aims.
Materials and Methods
Ethics Statement
The use of animals followed the requirements of the Cap. 340
Animals (Control of Experiments) Ordinance and Regulations in
Hong Kong. All the experimental and animal handling procedures
were approved by the Faculty Committee on the Use of Live
Animals in Teaching and Research in The University of Hong
Kong (CULATR #1850-09 and #1996-09).
Animals and Procedure
Adult female Sprague Dawley rats (10–12 weeks of age
weighing 250–280 g) were used in this study. The rats were
housed in a temperature-controlled room subjected to a 12-hour
light/12-hour dark cycle and supplied with food and water ad
libitum. The preparation of LBP was as previously described [8].
The final powder was stored in a dry-box and freshly dissolved in
phosphate - buffered saline (PBS; 0.01 M; pH 7.4) before use. The
treatment (LBP or PBS) began 1 week before surgery (CONT or
PONT) until sacrifice at the scheduled time-points (see Fig. 1). The
treatment was achieved with a feeding needle by gavage once
daily.
To investigate if the degeneration speeds were similar between
superior and inferior retinas after CONT, the rats without
treatment with PBS or LBP were sacrificed either 1 week or 2
weeks after CONT (n= 5 at either time-point). To evaluate the
effects of LBP on the survival of RGCs after ON injury, the
procedure was as described in Fig. 1. There were 4 to 16 animals
in each group: CONT: n=10, 8, 16 and 12 in PBS, 0.1 mg/kg
LBP, 1 mg/kg LBP and 10 mg/kg LBP groups sacrificed 1 week
after CONT. n= 7 and 6 in PBS and 1 mg/kg LBP groups
sacrificed 2 weeks after CONT. PONT: n= 7 and 4 in PBS and
LBP groups sacrificed 1 week after PONT. n=9 and 10 in PBS
and LBP groups sacrificed 4 weeks after PONT.
Figure 1. Schematic diagrams showing the procedures for the estimation of RGC survival. Rats were fed with PBS or LBP 1 week before
CONT or PONT until sacrifice. (A) In CONT experiments, CONT was performed and then a piece of gelatin soaked with FG was placed close to the ON
stump to label RGCs on day 0. Rats were sacrificed 1 week or 2 weeks after surgery. (B) In PONT experiments, SC labeling was performed 1 week
before PONT and rats were sacrificed 1 week or 4 weeks after surgery.
doi:10.1371/journal.pone.0068881.g001
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Retrograde labelling of RGCs was achieved using Fluoro-Gold
(FG) from the stump of the ON after CONT [17] or from superior
colliculi (SC) 1 week before PONT [18]. Seven rats without
treatment or ON injury were sacrificed 7 days after SC labeling as
controls for both CONT and PONT experiments. Eight animals
were used for 1, 19-dioctadecyl-3, 3, 39, 39-tetramethylindocarbo-
cyanine perchlorate (DiI) tracing in vivo. The death of cells in
ganglion cell layer (GCL) was studied using terminal deoxynu-
cleotidyl transferase-mediated dUTP-biotin nick end labeling
assay (TUNEL assay) and protein expression was examined with
Western-blot analysis at 12 hours, 1 day, 4 days and 1 week after
PONT; there was no drug treatment (n = 3 to 5 animals in each
group).
Protein expression after LBP or PBS treatment was also studied
with Western-blot analysis both 1 day and 1 week after PONT
(n=3 to 5 animals in each group). The rats for RGC counting
(both after FG and DiI labeling) and Western-blot analysis were
sacrificed using inhalation of CO2. For TUNEL assay, the rats
were sacrificed by injecting overdoses of Phenobarbital followed by
perfusion with 0.9% NaCl and 4% paraformaldehyde (PFA).
Surgical Procedure
Anesthesia and the CONT procedure were conducted as
previously described [17]. The PONT surgery was similar to that
described by Fitzgerald et al [8]. The partial incision in the ON
was made 1.0 mm from the optic disc and was achieved using a
pair of Spring Vannas scissors (15000-08, F.S.T., Heidelberg,
Germany) marked 200 mm from the tips of both blades, or using a
diamond knife (G-31480, Geuder AG, Hertzstrasse, Heldelberg,
Germany) with the blade fixed to a length of 200 mm.
Retrograde DiI Tracing in vivo after PONT
The method published by Fitzgerald et al. was adopted [8].
Briefly, the ON was partially cut and several crystals of DiI
(Molecular Probes, Eugene, OR) were placed precisely into the cut
sites to label the RGCs whose axons were transected (Fig. 2A). The
rats were sacrificed 4 days after DiI labeling. The retinas were
processed for RGC counting as below.
Optic nerves were collected, post-fixed in 4% PFA for 60
minutes and then placed into 30% sucrose in 0.1 M phosphate
buffer solution overnight until they sank. They were then
embedded into optimal cutting temperature embedding com-
pound and sectioned longitudinally. The sections were mounted
Figure 2. RGCs and ON labeled with DiI in vivo. (A) Schematic diagram of DiI labeling: after partial incision in the dorsal ON 1.0 mm from the
optic disc, several crystals of DiI were precisely placed into the incision. The DiI were transported to the retinas via the ends of the axons attached to
the eyeball. (B) More RGCs in the superior retinas were labeled with DiI than in the inferior retinas (Student t-test, **P = 0.001). (C) DiI labeled axons
were limited to the dorsal part of the ON. (D) Photographs about 1 mm from the optic disc in both the superior and inferior retinas showed the
different densities of DiI labeled RGCs. (n = 8).
doi:10.1371/journal.pone.0068881.g002
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on slides, rinsed 3 times with 0.01 M PBS and observed using
fluorescence microscopy.
Quantification of RGCs
After sacrifice, retinas were collected and post-fixed in 4% PFA
for 60 minutes. Retinas were divided into the superior and inferior
halves and each half was separated into three roughly equal sectors
before being flat-mounted as the temporal, middle and nasal
sectors (Fig. 3). Eight photographs (2006200 mm2) in each sector
were captured along the median line, starting from the optic disc
to the edges at 500-mm intervals under a fluorescence microscope
at 4006magnification [14,19]. The limitation of using photo-
graphs for cell counting rather than focusing through whole-
mounted retinas is that under-estimation may occur. However the
counting method is unlikely to alter the results of this experiment
and this method has the merit that the photographs can be kept
longer than sections and be recounted. Using rats without
treatment with PBS or LBP, we showed similar RGC surviving
densities between superior and inferior retinas either 1 week or 2
weeks after surgery (see Results). Therefore, for rats treated with
PBS or LBP, only inferior retinas were used after CONT. After
PONT, surviving RGCs were counted separately in superior and
inferior retinas because the degeneration speeds were different in
superior and inferior retinas after PONT [2], and grouped
together for the whole retinas. The counting was conducted by a
double-blind method by two persons and the data were averaged
(mean 6 SEM, numbers per mm2).
TUNEL Assay
TUNEL staining was previously believed to detect apoptosis
only, but more recently it has been shown to detect necrosis and
other types of cell death as well [20]. To determine when cell
death begins in the GCL, TUNEL staining was used to examine
retinas at different time-points after PONT. After sacrifice, the
eyeballs were post-fixed in 4% PFA overnight at 4uC, dehydrated
with a graded series of ethanol and xylene, and then embedded in
paraffin. Cross-sections (4 mm) were cut using a microtome (Micro
HM 315R, Heidelberg, Germany). Manufacturer’s instructions for
the TUNEL assay were followed (Roche Diagnostics GmbH,
Mannheim, Germany). Sections were counterstained with 49, 6-
diamidino-2-phenylindole (DAPI) after the TUNEL reaction to
confirm that the TUNEL staining was located in the nuclei. For
consistency of analysis, only sections with ON head were selected
for observation. Three sections were selected from each animal.
The positive-staining cells in the GCL in the inferior retinas were
counted under a microscope using a 4006magnification. The data
were expressed as mean 6 SEM, numbers per inferior retina.
Western-blot Analysis
After sacrifice, the inferior retinas were collected in PBS on ice.
The procedure including the use of lysis buffer, secondary
antibody and the developing reagents were as previously described
[17,19]. After transfer onto polyvinylidene difluoride membrane,
the membranes were blocked with 5% non-fat dry milk or 3%
bovine serum albumin in Tris-buffered saline with 0.05% Tween
Figure 3. Schematic diagram showing the method for taking photographs for RGC counting. Retinas were divided into the superior and
inferior halves and each half was separated into three sectors (temporal, middle, nasal) before being flat-mounted. Eight photographs each
2006200 mm2 were taken along the median line of each sector, starting from the optic disc to the border at 500 mm intervals. A total of 48
photographs per retina were taken.
doi:10.1371/journal.pone.0068881.g003
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20 for 1 hour. Rabbit polyclonal antibody tumor necrosis factor
alpha (TNF-a, 1:500), mouse monoclonal antibody manganese
superoxide dismutase (MnSOD or SOD2, 1:4000) and rabbit
polyclonal antibody brain-derived neurotrophic factor (BDNF,
1:100) were supplied by Abcam (Cambridge, MA, USA). Goat
anti-mouse polyclonal antibody insulin-like growth factor 1 (IGF-
1, 1:500) was purchased from R&D System (Minneapolis, USA).
Rabbit polyclonal antibodies phospho-c-jun N-terminal kinases (p-
JNKs, 1:500) and phospho-c-jun (p-c-jun, 1:500) were purchased
from Cell Signaling Technology (Beverly, MA, USA). The tissue
was incubated in Tris-buffered saline with 0.05% Tween 20
overnight at 4uC. The incubation of secondary antibody (dilution
1:10000 for MnSOD and 1:2000 for others) was conducted for 1
hour at room temperature. Protein loading was controlled using
the monoclonal mouse antibody against a-tubulin (1:20000,
Sigma-Aldrich, St. Louis, MO, USA). Densitometric analysis
was performed using Image J software (National Institutes of
Health, USA) with the scanned autoradiographic films.
Statistical Analysis
Student’s t-test was used for comparisons of two groups. For
more than two groups, one-way ANOVA was used for multiple
comparisons followed by Dunn’s or Student-Newman-Keuls
method as post hoc tests. Data were analyzed statistically with the
Sigmastat software (Sigmastat 3.5; Systat Software Inc., Chicago,
IL, USA). The P= 0.05 level was considered to be statistically
significant.
Results
RGCs Degenerated Significantly after CONT and PONT
The average densities of FG-labeled RGCs in the normal
retinas were as follows: the whole retinas: 2088.1664.4 RGCs/
mm2; the normal superior retinas: 2046.5692.4 RGCs/mm2; and
the normal inferior retinas: 2144.4689.8 RGCs/mm2. There was
no difference between the superior and inferior retinas (Student’s t-
test, P.0.05). The surviving RGC densities decreased significantly
in the expected areas after both CONT and PONT in animals
treated with PBS or LBP (Student’s t-test, P,0.001, Fig. 4 &
Fig. 5). The surviving densities of RGCs after CONT from
animals without treatment with PBS or LBP were as follows:
1510.7665.6 in the superior retinas and 1402.6674.7 in the
inferior retinas 1 week after CONT; 234.2619.8 in the superior
retinas and 214.868.4 in the inferior retinas 2 weeks after CONT.
There were no significant differences between the superior and
inferior retinas at both time-points after CONT (Student’s t-test,
P.0.05).
LBP did not Prevent the Primary Degeneration of RGCs
after CONT
One PBS group and three LBP groups with different dosages
(0.1 mg/kg, 1 mg/kg and 10 mg/kg) were examined 1 week after
CONT. No significant difference between the PBS group and any
LBP group was detected; in addition, no significant difference
among the three dosages of LBP was seen (one-way ANOVA for
multiple comparisons and Dunn’s method as post hoc tests:
Fig. 4A, 4C & 4D). We have previously found that 1 mg/kg LBP
can significantly reduce the death of RGCs 2 weeks and 4 weeks
after ocular hypertension produced by laser photocoagulation
[14], and therefore 1 mg/kg LBP was adopted in the later
experiments (CONT 2 weeks and PONT). Two weeks after
CONT, no significant difference between PBS and LBP groups
was detected (Student’s t-test, P.0.05, Fig. 4A, 4E & 4F).
LBP Delayed Secondary Degeneration of RGCs in the
Inferior Retina 4 Weeks after PONT
DiI labeled the cell bodies of RGCs whose axons were
transected after PONT and which would be expected to die from
primary degeneration. There were 460.9652.8 RGCs/mm2 and
191.2648.7 RGCs/mm2, labeled in the superior and inferior
retinas respectively. The difference was significant (P = 0.001,
Fig. 2B, 2D & 2E) and the ratio was about 2.4:1 between superior
and inferior retinas. These findings indicate that both superior and
inferior retinas are vulnerable to primary and secondary degen-
eration after PONT. However, in the inferior retinas, significantly
more RGCs would be affected by secondary injury since the
inferior retina has significantly fewer RGCs with axons transected
by PONT surgery.
LBP had no effect on the survival of RGCs in whole retinas
either 1 week or 4 weeks after PONT; comparison of the PBS and
LBP groups showed no difference between groups at either time-
point (Fig. 5A). When dividing the retinas into superior and
inferior halves, there was no difference in the superior retinas
between PBS and LBP groups either 1 week or 4 weeks after
PONT (Fig. 5B, 5D & 5E). LBP protected about 18% of RGCs in
the inferior retinas 4 weeks after the PONT but not 1 week after
PONT (one way ANOVA, p,0.05, Fig. 5B, 5G & 5H).
Combining the results from DiI labeling and the survival of
RGCs, our data show that LBP appears to delay secondary
degeneration of RGCs rather than to affect primary degeneration.
DiI Labeled Axons Located in the Dorsal ON
The sections from the optic nerves with retrograde labeling of
the RGCs by DiI showed that the travel path of DiI from the cut
site to the retinas was limited to the dorsal part of the nerve
(Fig. 2C).
Oxidative Stress and JNK Pathway(s) Involved in
Degeneration of RGCs in the Inferior Retina after PONT
In the inferior retinas, TUNEL staining showed that the
number of positive-staining cells increased significantly 1 week
after PONT (one way ANOVA, P,0.01). However, there were no
changes at 12 hours, 1 day and 4 days. The positive staining was
shown in the nuclei, which was confirmed by counter-staining with
DAPI (Fig. 6).
The protein level of TNF-a did not increase after PONT in the
inferior retinas (Fig. 7A). The expression of MnSOD increased
significantly 1 day after PONT and returned to normal level 4
days after PONT (Fig. 7B). The p-JNK/p-c-jun pathway was also
involved in the degeneration of RGCs in the inferior retinas.
Although the expression of p-JNK1 did not change, the level of p-
JNK2/3 increased 1 day after PONT and was maintained until 1
Figure 4. Effects of LBP on survival of RGCs 1 week and 2 weeks after CONT. RGCs were labeled by FG. The arrows indicate microglia which
were easily distinguished from RGCs and not counted. The blue arrowheads indicate RGCs. (A, C, D) Orally feeding of 0.1 mg/kg, 1 mg/kg and 10 mg/
kg LBP showed no significant effects on the survival of RGCs 1 week after CONT (compared with PBS group) and no significant difference among the
three different dosages of LBP groups was detected. (A, E, F) 1 mg/kg LBP showed no significant effects on the survival of RGCs 2 weeks after CONT
(compared with PBS group). (n = 10, 8, 16, 12 in PBS, 0.1 mg/kg LBP, 1 mg/kg LBP, 10 mg/kg LBP groups sacrificed 1 week after CONT and n=7 and 6
in PBS and 1 mg/kg LBP groups sacrificed 2 weeks after CONT.).
doi:10.1371/journal.pone.0068881.g004
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Figure 5. Effects of LBP on RGC survival 1 week and 4 weeks after PONT. The RGCs were labeled with FG. (A) LBP did not increase the
survival of RGCs either 1 week or 4 weeks after the PONT when the densities of surviving RGCs were produced from the whole retinas (NS: not
significant). (B) When the retinas were divided into the superior and inferior halves, LBP did not delay the degeneration of RGCs 1 week after PONT.
However, it reduced the degeneration of RGCs in the inferior retina (*P = 0.027) but not in the superior retina 4 weeks after the PONT. (F – H) The
photographs of RGCs labeled by FG in both the superior and inferior retinas are about 1.5 mm away from the optic disc. In the superior retinas, the
densities of RGCs were similar between the PBS and LBP groups. In the inferior retinas, the density of RGCs in the LBP group was higher than that in
the PBS group. Microglia (white arrows) were easily distinguished from RGCs and not counted. (n = 7 and 4 in PBS and LBP groups 1 week after PONT.
n = 9 and 10 in PBS and LBP groups 4 weeks after PONT.).
doi:10.1371/journal.pone.0068881.g005
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week (Fig. 7C). P-c-jun increased with the same tendency as p-
JNK2/3 (Fig. 7D).
LBP Inhibited Oxidative Stress and Activation of JNK
Pathway as well as Transiently Increasing the Expression
of IGF-1 in the Inferior Retina
After LBP treatment, the expression of MnSOD increased
significantly 1 day after PONT (Fig. 8A & Fig. 9A). On the other
hand, LBP treatment significantly decreased the expression of p-
JNK2/3 and p-c-jun both 1 day and 1 week after PONT (Fig. 8B,
8C & Fig. 9B, 9C). The effects of LBP on the expression BDNF
and IGF-1 were as follows: after PONT, LBP did not change the
expression of BDNF either 1 day or 1 week after PONT (Fig. 8D
& Fig. 9D). However, LBP increased the expression of IGF-1 1 day
after PONT, but the effect was not maintained at 1 week (Fig. 8E
& Fig. 9E).
Discussion
After CONT, most RGCs died rapidly from primary degener-
ation. After PONT, more RGCs die from secondary degeneration
at a later time-window in addition to primary degeneration [2,6].
Our results showed that LBP did not delay primary degeneration
of RGCs after CONT. However, LBP did delay secondary
degeneration of RGCs 4 weeks after PONT. Levkovitch-Verbin
et al. showed that although the genetic profile was similar for
primary and secondary degeneration of RGCs, minocycline was
only effective for secondary degeneration, indicating a potential
difference between the two types of degeneration [21]. Our result
was consistent with this in that LBP only delayed secondary
degeneration but not primary degeneration.
In the PONT model, the increasing expression of MnSOD or
SOD2, which was demonstrated by immunohistochemistry (IHC),
was used as an indicator of oxidative stress [7,22,23]. MnSOD is
an anti-oxidant enzyme and can detoxify in cells and tissues by
converting toxic superoxide into hydrogen peroxide and diatomic
oxygen. Administration of adeno-associated virus containing the
SOD2 gene into eyes significantly reduces oxidative stress and
nitrative stress in a rat acute ocular hypertension model [24]. The
protective effect of LBP for RGCs was related to the anti-oxidative
mechanism [19]. In order to determine if the anti-oxidant ability
of LBP for RGCs was related to MnSOD, we investigated the
expression levels of MnSOD in the rats treated with LBP or
vehicle, and our results confirmed the anti-oxidant effect of LBP in
retinas after injury.
JNKs are the kinases involved in both apoptotic and non-
apoptotic cell death [25,26]. C-jun is a transcription factor
activated by phosphorylation of JNKs and is involved in the
transcription of various proteins, including some pro-apoptotic
proteins [26]. Previous studies using the PONT model and IHC
staining have shown that JNKs are activated at the primary injury
sites and c-jun is activated both at the primary and the secondary
injury sites in the retina [7,27]. There are three isoforms of JNKs:
JNK1, JNK2 and JNK3; IHC cannot differentiate among these
isoforms. We used Western-blot analysis, to differentiate JNK1
from JNK2/3 according to the molecular weights. Our results
confirmed the inhibition of the JNK/c-jun pathway by LBP; this
effect has been shown previously using different models [28,29].
However, this is the first time that these effects of LBP have been
demonstrated in the retina. In addition, our results showed that p-
JNK2/3 rather than p-JNK1 were activated in the inferior retina
after PONT. A similar result has been shown in cultured RGC-5
cells: advanced glycation end products–albumin from bovine
serum increased the production of p-JNK2/3, but not p-JNK1
in vitro [30].
BDNF belongs to the neurotrophin family and is expressed both
in SC [31,32] and retina [33]. The level of BDNF increases in
retina following ON transection [34] and after periocular injection
of in situ hydrogels containing Leu-Ile. This is an inducer for
neurotrophic factors, which increase the expression of BDNF in
Figure 6. TUNEL staining in the inferior retinas after PONT. (A) The number of positive-staining cells increased significantly in the inferior
retinas 1 week after PONT, compared with the normal retinas (P,0.01). There were no significant differences between normal and any other group.
(B) The positive cells in the GCL of the inferior retina 1 week after PONT (red). The positive staining was located in the nuclei (C, D), which is shown
with DAPI (blue). (n = 4, 3, 3, 5 and 4 in normal, 12 h, 1d, 4d and 1w groups respectively.).
doi:10.1371/journal.pone.0068881.g006
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the retina and promote RGC survival after ON injury [35]. IGF-1
is also a neurotrophic factor which is a key molecule determining
the survival of RGCs during the early stage of ON injury [36].
However, the effects of LBP on the expression of BDNF and IGF-
1 have not been previously studied. Our results show that LBP can
produce a transient increase in the expression of IGF-1 in the
inferior retina, but the source of this IGF-1 is not clear. Future
study using IHC with this model may help to address this issue.
It is known that DiI could be transported by either active
processes or by diffusion [6,37–40]. In this experiment, DiI was
used to label RGCs whose axons were transected after PONT.
Although it has been reported that DiI can label cells in close
proximity to labeled cells in fixed tissues [37], this phenomenon
has not been reported in vivo [40]. Perhaps the time available for
DiI labeling for fixed tissues was much longer than that in vivo;
diffusion to neighboring tissue was obvious in fixed tissues but not
for the tissues in vivo. Therefore, we did an in vivo study where
diffusion of DiI was limited. Our results also showed that the
axonal transport of DiI was limited to the dorsal region in the ON
Figure 7. Western-blot analysis of the inferior retinas after PONT. Each band from one animal. (A) The expression levels of TNF-a in the
inferior retinas did not change after PONT at different time-points (P.0.05). (B) MnSOD level increased significantly 1 day after PONT and had
returned to normal 4 days after PONT (*P,0.05) (C) P-JNK1 level did not change after PONT (P.0.05). P-JNK2/3 levels increased significantly from 1
day until 1 week after PONT (*P,0.05). (D) The levels of p-c-jun increased from 1 day until 1 week after PONT (*P,0.05). (n = 3 in each group.).
doi:10.1371/journal.pone.0068881.g007
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sections from the labeled animals and where diffusion was
insignificant.
Our results confirmed the neuroprotective effects of LBP
for RGCs and showed the possible mechanism. The future
target of our study is to provide the basis for the use of LBP in
clinical conditions. The electroretinogram is used widely by
ophthalmologists and optometrists for the diagnosis of retinal
diseases and can evaluate the retinal function by measuring the
electrical responses of various cell types [41–45]. Therefore, we
have also used the electroretinogram to evaluate the effect of LBP
after PONT and this experiment is currently in process.
Figure 8. Western-blot analysis of the inferior retinas after treatment with PBS or LBP. Each band is from one animal. (A) The expression
of MnSOD 1 day after PONT both in PBS and LBP groups. (B, C, D, E) The expressions of p-JNK2/3, p-c-jun, BDNF, IGF-1 both 1 day and 1 week after
PONT both in PBS and LBP groups. (n = 3, 3, 5 and 4 in PBS 1 day, LBP 1 day, PBS 1 week and LBP 1 week groups respectively.).
doi:10.1371/journal.pone.0068881.g008
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